Evaluation of the factors associated with bradtycardia following pulmonary vein isolation using pulsed field ablation
NCT ID NCT07809347
First seen Sep 09, 2026 · Last updated Sep 09, 2026
Summary
The study aims to identify factors associated with bradycardia during the hospital stay after ablation of atrial fibrillation performed with pulsed field technology.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Consecutive patients undergoing PVI using PFA for the treatment of atrial fibrillation.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- Pulmonary vein isolation performed with PFA Exclusion Criteria: * Permanent pacemaker * CRT device * Dual-chamber ICD * Cardiac tamponade * Acute stroke * Acute bleeding requiring surgical intervention
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Atrial fibrillation (AF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Institute of Heart Diseases, Wroclaw Medical University
RECRUITINGWroclaw, Lower Silesian Voivodeship, 50-556, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The impact of video-based cardiac rehabilitation education in patients with cardiovascular implantable electronic Devices(CIEDs)- a randomized controlled trial
- Can remote exercise sessions boost heart recovery after ablation?
- Which pacing target keeps the heart stronger? a trial aims to find out
- Can a pacemaker slip in through the neck vein?
- Can a heart drug keep atrial fibrillation at bay after ablation?
- Can a new drug stop long atrial fibrillation episodes?